SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Tomorrow.io raises $175 million at over $1 billion valuation to build AI-driven weather satellite network

Cyber startup Orion raises $32 million Series A backed by IBM for AI-driven data-leak prevention

Full list of Israeli startup M&As in 2026

Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion

Buzz

Most popular

Daily

Weekly

1

Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”

2

Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race

3

After $400M cyber exit, ex-IntSights CEO raises $11M to build AI app for personalized sports highlights

4

Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion

5

Why Apple paid billions for a company with no revenue

Copaxone

4 stories about Copaxone

חברת ה תרופות טבע Teva

Teva’s Stock Drops After Approval of Copaxone Competitors

08.10.17|Lilach Baumer

A day after Mylan announced FDA approval for its generic versions of Copaxone, drug companies Synthon and Alvogen announce European approval for their 40 mg/ml generic versions of Teva's blockbuster drug

Teva Loses Copaxone Market Exclusivity

04.10.17|Lilach Baumer

Rival Mylan received FDA approval for its generic versions of Copaxone, Teva’s flagship drug

מנכ"ל טבע החדש קור שולץ 2

New CEO to Break Teva’s Copaxone Habit

11.09.17|Sophie Shulman, Dror Reich

Troubled drugmaker says new CEO must work to quickly regain its financial credibility

תרופות טבע גלולות תרופה

With Bloated Debt, Teva Looks to Sell Assets

10.08.17|Eli Shimony and Gil Kalian

The generic drugmaker said it is looking to sell Medis, an Iceland-based company it bought in 2016

Previous Articles